Načítá se...
Infliximab relieves blood retinal barrier breakdown through the p38 MAPK pathway in a diabetic rat model
AIM: To clarify the mechanism of infliximab treatment in diabetic macular edema (DME) and to provide a new alternative therapy for DME. METHODS: Rats were randomly divided into the control group, the model group and the infliximab treatment group. A diabetic rat model was created. The concentration...
Uloženo v:
| Vydáno v: | Int J Ophthalmol |
|---|---|
| Hlavní autoři: | , , , |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
International Journal of Ophthalmology Press
2017
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5733508/ https://ncbi.nlm.nih.gov/pubmed/29259899 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.18240/ijo.2017.12.06 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|